These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32489563)

  • 21. Treadmill exercise alleviates neuronal damage by suppressing NLRP3 inflammasome and microglial activation in the MPTP mouse model of Parkinson's disease.
    Wang W; Lv Z; Gao J; Liu M; Wang Y; Tang C; Xiang J
    Brain Res Bull; 2021 Sep; 174():349-358. PubMed ID: 34224819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.
    Hung HC; Lee EH
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):14-26. PubMed ID: 8883930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
    Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ginsenoside Rg1 modulates COX-2 expression in the substantia nigra of mice with MPTP-induced Parkinson disease through the P38 signaling pathway].
    Wang Q; Zheng H; Zhang ZF; Zhang YX
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1594-8. PubMed ID: 18819875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of the oil from ganoderma lucidum spores on pathological changes in the substantia nigra and behaviors of MPTP-treated mice].
    Zhu WW; Liu ZL; Xu HW; Chu WZ; Ye QY; Xie AM; Chen L; Li JR
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):667-71. PubMed ID: 15958304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
    Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
    Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats.
    Xu CL; Qu R; Zhang J; Li LF; Ma SP
    Fitoterapia; 2013 Oct; 90():112-8. PubMed ID: 23876367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
    J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hippocampal damage and white matter lesions contribute to cognitive impairment in MPTP-lesioned mice with chronic cerebral hypoperfusion.
    Gao Y; Tang H; Nie K; Zhu R; Gao L; Feng S; Wang L; Zhao J; Huang Z; Zhang Y; Wang L
    Behav Brain Res; 2019 Aug; 368():111885. PubMed ID: 30959125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin.
    Li C; Biswas S; Li X; Dutta AK; Le W
    J Neurosci Res; 2010 Aug; 88(11):2513-23. PubMed ID: 20623619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.
    Ji C; Xue GF; Lijun C; Feng P; Li D; Li L; Li G; Hölscher C
    Brain Res; 2016 Mar; 1634():1-11. PubMed ID: 26453833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
    Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA
    Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycine nano-selenium prevents brain oxidative stress and neurobehavioral abnormalities caused by MPTP in rats.
    Yue D; Zeng C; Okyere SK; Chen Z; Hu Y
    J Trace Elem Med Biol; 2021 Mar; 64():126680. PubMed ID: 33242795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).
    Ito T; Suzuki K; Uchida K; Nakayama H
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):153-8. PubMed ID: 21855308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of intermittent washout periods on progressive lesioning of the nigrostriatal pathway with 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Goldberg NR; Meshul CK
    Neuroscience; 2011 May; 182():203-7. PubMed ID: 21402128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of phosphorylated-ERK1/2 on inducible nitric oxide synthase expression in the substantia nigra of mice with MPTP-induced Parkinson disease].
    Shi C; Zhang YX; Zhang ZF
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):60-3. PubMed ID: 19218114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of treadmill exercise on hippocampal neurogenesis in an MPTP /probenecid-induced Parkinson's disease mouse model.
    Sung YH
    J Phys Ther Sci; 2015 Oct; 27(10):3203-6. PubMed ID: 26644675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposite effects of bone marrow-derived cells transplantation in MPTP-rat model of Parkinson's disease: a comparison study of mononuclear and mesenchymal stem cells.
    Capitelli CS; Lopes CS; Alves AC; Barbiero J; Oliveira LF; da Silva VJ; Vital MA
    Int J Med Sci; 2014; 11(10):1049-64. PubMed ID: 25136260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.
    Petzinger GM; Walsh JP; Akopian G; Hogg E; Abernathy A; Arevalo P; Turnquist P; Vucković M; Fisher BE; Togasaki DM; Jakowec MW
    J Neurosci; 2007 May; 27(20):5291-300. PubMed ID: 17507552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
    Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.